Virus Diseases  >>  radalbuvir (GS-9669)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
radalbuvir (GS-9669) / Gilead
NCT01260350: Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

Checkmark EASL 2014: ELECTRON
Mar 2014 - Mar 2014: EASL 2014: ELECTRON
Checkmark APASL 2014: ELECTRON
Mar 2014 - Mar 2014: APASL 2014: ELECTRON
Checkmark HepDART 2013: LONESTAR & ELECTRON
More
Completed
2
292
RoW
SOF, Sovaldi®, GS-7977, PSI-7977, RBV, Copegus®, PEG, Pegasys®, LDV, GS-5885, GS-9669, LDV/SOF, Harvoni®
Gilead Sciences
Chronic Hepatitis C Infection
10/13
12/13
NCT01826981: Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Completed
2
359
RoW
LDV/SOF, Harvoni®, GS-5885/GS-7977, SOF, GS-7977, Sovaldi®, RBV, Peg-IFN, Pegasys®, GS-9669, VEL, GS-5816
Gilead Sciences
Chronic Hepatitis C
03/15
05/15
NCT01805882: Combination Therapy for Chronic Hepatitis C Infection

Checkmark AASLD 2014: SYNERGY
Oct 2014 - Oct 2014: AASLD 2014: SYNERGY
Checkmark EASL 2014: SYNERGY
Mar 2014 - Mar 2014: EASL 2014: SYNERGY
Checkmark APASL 2014: SYNERGY
More
Completed
2
229
US
Sofosbuvir, Sofosbuvir (GS-7977), Ledipasvir, Ledipasvir (GS-5885), GS-9669, GS-9451
National Institute of Allergy and Infectious Diseases (NIAID)
Hepatitis C, Chronic
08/15
08/15

Download Options